Drugs / Alga Dunaliella Bardawil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01121081 | Jan 2010 → Jan 2011 | psoriasis | Sheba Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alga Dunaliella Bardawil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01121081 ↗ |
| Route | Oral | “daily oral administration of Dunaliella or placebo” NCT01121081 ↗ |